Can You Calculate Vancomycin AUC Using Trough Only?
Yes, you can calculate vancomycin AUC using trough-only data with acceptable accuracy, particularly when using modern Bayesian software or validated population pharmacokinetic models, though two-point sampling (peak and trough) may provide marginally better precision in certain clinical scenarios.
Historical Context and Guideline Framework
The 2009 IDSA/ASHP/SIDP guidelines established AUC/MIC ≥400 as the therapeutic target for vancomycin, with trough concentrations of 15-20 mg/L expected to achieve this target when MIC ≤1 mg/L 1. However, these guidelines were developed before widespread availability of sophisticated AUC calculation tools and primarily recommended trough-only monitoring as "the most accurate and practical method" 1.
Current Evidence on Trough-Only AUC Estimation
Bayesian Software Approaches
Recent high-quality studies demonstrate that trough-only AUC estimation using Bayesian software achieves clinically acceptable accuracy:
- A 2023 study using MwPharm++ software showed trough-only predictions had a median prediction error of -1.6% and median absolute prediction error of 12.4%, compared to -6.2% and 16.9% respectively when using both peak and trough 2
- In patients with BMI ≥40 kg/m², 97.5% of trough-only AUC estimates were within ±20% of two-concentration estimates (mean difference: 2.9%) 3
- A 2026 study found that 75% of trough-only AUC calculations were within 5% of peak-trough calculations when using an updated population pharmacokinetic model 4
Critical Caveat: Model Selection Matters More Than Sampling Strategy
The population pharmacokinetic model used has far greater impact on accuracy than whether you use one or two concentrations 3. When comparing different models, only 59.1% of estimates agreed within ±20%, whereas trough-only versus peak-trough comparisons using the same model showed >97% agreement 3.
Practical Algorithm for AUC Calculation
When Trough-Only Is Sufficient:
- Stable renal function (creatinine clearance >30 mL/min)
- BMI <40 kg/m² (though validated up to BMI ≥40)
- Not critically ill with rapidly changing physiology
- Using validated Bayesian software (e.g., VancoPK, InsightRx with appropriate models)
- Targeting mid-range AUC (400-600 μg·h/mL)
When Two-Point Sampling Is Preferred:
- Acute kidney injury or unstable renal function 3
- Critically ill patients with augmented renal clearance
- Targeting AUC at extremes of therapeutic range 3
- Poor model fit on initial estimation
- Creatinine clearance >130 mL/min 5
Specific Calculation Methods
Using Online Calculators (Trough-Only)
A 2023 comparison of open-access calculators found VancoPK showed no significant difference from the trapezoidal method (median actual difference: -0.8, P=0.827), while ClinCalc and VancoVanco showed significant deviations 6. VancoPK resulted in discordant dose adjustments in only 12% of cases versus 28-36% for other calculators 6.
Volume of Distribution Models
For trough-only calculations without Bayesian software, the VancoPK equation provides reasonable accuracy 7:
Vd = 0.29(age in years) + 0.33(actual weight in kg) + 11
Using this model, approximately 95% of AUC estimates fall within ±95 mg·h/L of peak-trough calculated AUCs 7. This means targeting an estimated AUC of 500 mg·h/L would likely result in actual AUC of 400-600 mg·h/L 7.
Common Pitfalls to Avoid
Using outdated population models: The Oda model (2026) significantly outperformed the older Yasuhara model, with 75% versus 58.3% of estimates within 5% accuracy 4
Assuming all Bayesian software is equivalent: Different software packages use different population models, leading to substantial variability in AUC estimates 3
Ignoring timing of trough sample: Must be obtained at steady state (just before 4th dose) and truly at trough (immediately before next dose) 1
Applying to pediatric patients: All validation studies were in adults; pediatric dosing requires different approaches 1
Enhanced Accuracy Strategies
When using trough-only estimation, measure the first peak concentration after the initial dose to calculate patient-specific volume of distribution (Vd,app = First dose / First peak concentration), then use subsequent trough-only measurements 5. This hybrid approach showed correlation of 0.643 (P<0.01) with Bayesian methods 5.
For critically ill patients requiring AUC >400 μg·h/mL on day 1, empirical dosing of approximately 50 mg/kg on the first day (divided doses) is recommended, followed by two-point sampling for Bayesian refinement 8.
Bottom Line for Clinical Practice
Trough-only AUC estimation is clinically acceptable for most patients when using validated Bayesian software or the VancoPK model, eliminating the need for peak sampling in routine cases. However, obtain both peak and trough in critically ill patients, those with unstable renal function, or when initial estimates show poor model fit. The choice of calculation method and population model matters more than the number of concentrations measured.